MeTC7
MeTC7 is a Vitamin-D receptor (VDR) antagonist. MeTC7 has potent VDR inhibition activity with an IC50 value of 2.9 μM. MeTC7 shows good antitumor effects[1].
Product Specifications
CAS Number
1817841-22-7
UNSPSC
12352005
Target
VD/VDR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/metc7.html
Purity
98.50
Solubility
DMSO : ≥ 16.67 mg/mL
Smiles
O=C1N2C34[C@@](CC[C@]5([C@@]4([H])CC[C@]5([H])[C@H](C)CCCC(C)C)C)([H])[C@@]6(C(C=C3)(C[C@H](CC6)OC(CBr)=O)N2C(N1C)=O)C
Molecular Formula
C32H48BrN3O4
Molecular Weight
618.65
References & Citations
[1]Negar Khazan, et al. Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors In Vivo. J Med Chem
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY421331 100 µg
C17orf89 (NDUFAF8) (NM_001086521) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC042175-500 1x 500 µL
Cytokeratin 8 (KRT8) (rB22.1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
